The Cooper Companies, Inc. $COO Shares Sold by Swedbank AB

Swedbank AB trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 23.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 819,229 shares of the medical device company’s stock after selling 254,800 shares during the period. Swedbank AB’s holdings in Cooper Companies were worth $58,575,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in COO. Capital World Investors raised its position in shares of Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after acquiring an additional 2,159,233 shares in the last quarter. State Street Corp boosted its holdings in Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after purchasing an additional 207,195 shares in the last quarter. Wellington Management Group LLP increased its stake in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. Finally, Sustainable Growth Advisers LP lifted its position in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after buying an additional 747,476 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Down 1.0%

Shares of Cooper Companies stock opened at $71.89 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company has a market capitalization of $14.02 billion, a P/E ratio of 60.92, a PEG ratio of 1.90 and a beta of 0.84. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company’s fifty day moving average is $64.81 and its two-hundred day moving average is $73.18.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the prior year, the company earned $0.96 earnings per share. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the topic of several research analyst reports. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research note on Wednesday, May 27th. Robert W. Baird dropped their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. JPMorgan Chase & Co. cut their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Finally, Needham & Company LLC reduced their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.